{"id":386,"date":"2026-01-26T14:45:30","date_gmt":"2026-01-26T13:45:30","guid":{"rendered":"https:\/\/ced-studienzentrum.berlin\/2026\/01\/26\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/"},"modified":"2026-02-03T11:01:12","modified_gmt":"2026-02-03T10:01:12","slug":"crohns-disease-study-on-subcutaneous-guselkumab-graviti","status":"publish","type":"post","link":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/","title":{"rendered":"Crohn&#8217;s disease: Study on subcutaneous guselkumab (GRAVITI)"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Listings&#8221; module_id=&#8221;target group&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;custom&#8221; background_image_width=&#8221;90%&#8221; background_position=&#8221;bottom_right&#8221; top_divider_height=&#8221;51px&#8221; locked=&#8221;off&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;3&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_margin=&#8221;|auto|-1px|auto|false|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_post_title meta=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; title_text_color=&#8221;#10344C&#8221; title_font_size=&#8221;45px&#8221; custom_margin=&#8221;||15px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_post_title][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;1f09816e-184e-4ce5-a4cf-b39c52c423ca&#8221; text_font=&#8221;&#8211;et_global_body_font||||||||&#8221; text_text_color=&#8221;#10344C&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;1.8em&#8221; ul_line_height=&#8221;1.8em&#8221; custom_margin=&#8221;||||false|false&#8221; hover_enabled=&#8221;0&#8243; text_font_size_tablet=&#8221;15px&#8221; text_font_size_phone=&#8221;14px&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; header_font_size_tablet=&#8221;55px&#8221; header_font_size_last_edited=&#8221;off|desktop&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong>ClinicalTrials.gov ID:<\/strong> NCT05197049<br \/><strong>Sponsor:<\/strong> Janssen Research &amp; Development, LLC<\/p>\n<p><strong>Official title:<\/strong><br \/>Randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of subcutaneous guselkumab induction therapy in moderately to severely active Crohn&#8217;s disease.<\/p>\n<p><strong>Study overview:<\/strong><br \/>Evaluation of the efficacy and safety of guselkumab in patients with Crohn&#8217;s disease.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ClinicalTrials.gov ID: NCT05197049Sponsor: Janssen Research &amp; Development, LLC Official title:Randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of subcutaneous guselkumab induction therapy in moderately to severely active Crohn&#8217;s disease. Study overview:Evaluation of the efficacy and safety of guselkumab in patients with Crohn&#8217;s disease.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[37,36],"tags":[],"class_list":["post-386","post","type-post","status-publish","format-standard","hentry","category-active-recruitment-completed","category-for-study-partners"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crohn&#039;s disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crohn&#039;s disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst\" \/>\n<meta property=\"og:description\" content=\"Who our studies are suitable forWe conduct clinical studies for individuals with moderate to severe chronic inflammatory bowel diseases. Both early and advanced stages of the disease can be considered. Whether participation is possible always depends on the specific medical inclusion criteria of the study. These will be explained in detail during the information session.Quality [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/\" \/>\n<meta property=\"og:site_name\" content=\"CED Studienzentrum Karlshorst\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-26T13:45:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-03T10:01:12+00:00\" \/>\n<meta name=\"author\" content=\"Pauline Lauterbach\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pauline Lauterbach\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/\"},\"author\":{\"name\":\"Pauline Lauterbach\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/#\\\/schema\\\/person\\\/bb726445dbde6c212a82ef1d1ec3fdeb\"},\"headline\":\"Crohn&#8217;s disease: Study on subcutaneous guselkumab (GRAVITI)\",\"datePublished\":\"2026-01-26T13:45:30+00:00\",\"dateModified\":\"2026-02-03T10:01:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/\"},\"wordCount\":271,\"articleSection\":[\"Active, recruitment completed\",\"For study partners\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/\",\"url\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/\",\"name\":\"Crohn's disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/#website\"},\"datePublished\":\"2026-01-26T13:45:30+00:00\",\"dateModified\":\"2026-02-03T10:01:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/#\\\/schema\\\/person\\\/bb726445dbde6c212a82ef1d1ec3fdeb\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/ced-study-center-karlshorst\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crohn&#8217;s disease: Study on subcutaneous guselkumab (GRAVITI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/\",\"name\":\"CED Studienzentrum Karlshorst\",\"description\":\"Dr. Thomas Brunk\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/#\\\/schema\\\/person\\\/bb726445dbde6c212a82ef1d1ec3fdeb\",\"name\":\"Pauline Lauterbach\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g\",\"caption\":\"Pauline Lauterbach\"},\"url\":\"https:\\\/\\\/ced-studienzentrum.berlin\\\/en\\\/author\\\/paulilauterbachnutzer\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crohn's disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/","og_locale":"en_US","og_type":"article","og_title":"Crohn's disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst","og_description":"Who our studies are suitable forWe conduct clinical studies for individuals with moderate to severe chronic inflammatory bowel diseases. Both early and advanced stages of the disease can be considered. Whether participation is possible always depends on the specific medical inclusion criteria of the study. These will be explained in detail during the information session.Quality [&hellip;]","og_url":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/","og_site_name":"CED Studienzentrum Karlshorst","article_published_time":"2026-01-26T13:45:30+00:00","article_modified_time":"2026-02-03T10:01:12+00:00","author":"Pauline Lauterbach","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pauline Lauterbach","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/#article","isPartOf":{"@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/"},"author":{"name":"Pauline Lauterbach","@id":"https:\/\/ced-studienzentrum.berlin\/en\/#\/schema\/person\/bb726445dbde6c212a82ef1d1ec3fdeb"},"headline":"Crohn&#8217;s disease: Study on subcutaneous guselkumab (GRAVITI)","datePublished":"2026-01-26T13:45:30+00:00","dateModified":"2026-02-03T10:01:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/"},"wordCount":271,"articleSection":["Active, recruitment completed","For study partners"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/","url":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/","name":"Crohn's disease: Study on subcutaneous guselkumab (GRAVITI) - CED Studienzentrum Karlshorst","isPartOf":{"@id":"https:\/\/ced-studienzentrum.berlin\/en\/#website"},"datePublished":"2026-01-26T13:45:30+00:00","dateModified":"2026-02-03T10:01:12+00:00","author":{"@id":"https:\/\/ced-studienzentrum.berlin\/en\/#\/schema\/person\/bb726445dbde6c212a82ef1d1ec3fdeb"},"breadcrumb":{"@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ced-studienzentrum.berlin\/en\/crohns-disease-study-on-subcutaneous-guselkumab-graviti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/ced-studienzentrum.berlin\/en\/ced-study-center-karlshorst\/"},{"@type":"ListItem","position":2,"name":"Crohn&#8217;s disease: Study on subcutaneous guselkumab (GRAVITI)"}]},{"@type":"WebSite","@id":"https:\/\/ced-studienzentrum.berlin\/en\/#website","url":"https:\/\/ced-studienzentrum.berlin\/en\/","name":"CED Studienzentrum Karlshorst","description":"Dr. Thomas Brunk","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ced-studienzentrum.berlin\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ced-studienzentrum.berlin\/en\/#\/schema\/person\/bb726445dbde6c212a82ef1d1ec3fdeb","name":"Pauline Lauterbach","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f53e1cd99af695e65f7049f9a6e8f851d6a975dd071101a4b88873ebace39780?s=96&d=mm&r=g","caption":"Pauline Lauterbach"},"url":"https:\/\/ced-studienzentrum.berlin\/en\/author\/paulilauterbachnutzer\/"}]}},"_links":{"self":[{"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/posts\/386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/comments?post=386"}],"version-history":[{"count":3,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/posts\/386\/revisions"}],"predecessor-version":[{"id":389,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/posts\/386\/revisions\/389"}],"wp:attachment":[{"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/media?parent=386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/categories?post=386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ced-studienzentrum.berlin\/en\/wp-json\/wp\/v2\/tags?post=386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}